Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Effect of BIA 9-1067 on Rasagiline Pharmacokinetics [Phase 1]
Phase 1 trial assessing whether BIA 9-1067 alters the pharmacokinetics of rasagiline in Parkinson disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa [Phase 1]
Phase 1 pharmacokinetic/pharmacodynamic study evaluating the interaction between three single doses of BIA 9-1067 and a single dose of immed…
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A
This update reports the completion of AFF008E, an observational Phase 1b follow-up extension study of Parkinson's disease patients immunized…
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease [Phase 1]
Phase 1 trial update evaluating tolerability and safety of two subcutaneous doses of AFFITOPE PD01A in early Parkinson's disease. The study …
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity [Phase 1]
Follow-up Phase 1 study evaluating a single booster of AFFITOPE PD01A for safety and clinical activity in Parkinson's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease
This clinical trial update summarizes the safety and efficacy findings from a completed study of long-term daily Mirapex LA use in Parkinson…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients [Phase 3]
A Phase 3 double-blind study comparing rotigotine to placebo in early-stage idiopathic Parkinson's disease. The study results have been post…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Rasagiline and Apathy in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluated rasagiline for apathy in Parkinson's disease and has completed.
-
FDA approval · 2015-08-07FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved a generic pramipexole dihydrochloride product from Dr. Reddy's Laboratories Limited; indicated for Parkinson's disease and rest…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease [NA]
The study evaluating lower-extremity ankle-foot orthoses in Parkinson's disease was terminated, and its results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-07-23Clinical Trial Update: The Effect of LSVT LOUD for Mandarin-speaking Individuals With Hypokinetic Dysarthria Due to Parkinson's Disease [NA]
Trial update on LSVT LOUD for Mandarin-speaking individuals with hypokinetic dysarthria due to Parkinson's disease. The current status of th…
-
CLINICAL_TRIALS research · 2015-07-21Clinical Trial Update: The Effect of tDCS on a Motor-cognitive Dual-task Performance of Parkinson's Patients [NA]
This clinical trial update describes a study evaluating the effect of transcranial direct current stimulation (tDCS) on motor-cognitive dual…
-
FDA approval · 2015-07-20FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline) from Teva Neuroscience, Inc., authorizing changes to the product's labe…
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Intravenous Versus Inhalational Anesthesia in Parkinson's Disease [NA]
A terminated clinical trial comparing intravenous versus inhalational anesthesia in Parkinson's disease, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients [NA]
A clinical trial update reports evidence of neuroplasticity after performing a cognitive task in patients with Parkinson's disease. The stud…
-
CLINICAL_TRIALS research · 2015-07-07Clinical Trial Update: Can tDCS Enhance Efficacy of Rehabilitative Intervention for Freezing of Gait in Parkinson's Disease? [NA]
This clinical trial investigates whether adding transcranial direct current stimulation to a rehabilitative program improves freezing of gai…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa) [Phase 1]
A Phase 1 study update assessing the tolerability of the oral levodopa/carbidopa combination (Sinemet) in healthy subjects; the trial is rep…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Balance Training in Parkinson's Disease Using Cues [Phase 3]
Phase 3 trial evaluating balance training using cues in Parkinson's disease has completed.
-
CLINICAL_TRIALS research · 2015-06-26Clinical Trial Update: The Use of Botox in Advanced Parkinson's Patients Experiencing Pain [Phase 4]
This clinical trial update reports on the use of Botox (onabotulinumtoxinA) for pain in advanced Parkinson's disease patients. The study is …
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease [NA]
A clinical trial comparing modafinil and methylphenidate for excessive daytime sleepiness in Parkinson's disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Naltrexone for Impulse Control Disorders in Parkinson's Disease [Phase 4]
This document reports the completion of a Phase 4 trial evaluating naltrexone for impulse control disorders in Parkinson's disease, with res…
-
FDA approval · 2015-06-19FDA Approved: ENTACAPONE — Original Application (Aurobindo Pharma Limited)
FDA approves the original application (ANDA) for entacapone tablets from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Amplitude and Rate of Intrinsic Feedback During Treadmill Training for Parkinson's Disease [NA]
This is a clinical trial update on intrinsic feedback during treadmill training for Parkinson's disease. The study has completed with result…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Mindfulness Based Intervention (MBI) on the Quality of Life and Non-Motor Symptoms (NMS) of Persons With PD [Phase 2]
This update reports the completion of a Phase 2 clinical trial investigating a mindfulness-based intervention to improve quality of life and…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects [Phase 1]
This clinical trial update reports the completion of a Phase 1 pilot study at Duke University assessing treatment effects and adherence in i…